Data / Drug companies / Reducing and Complexing Thiol
Reducing and Complexing Thiol drugs: 1 drug from 8 companies in the FDA NDC directory
Reducing and Complexing Thiol is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 16 products in this class from 8 companies, covering 1 drug by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on September 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 8Companies
- 16Products
- 1Drugs by generic name
Drugs in the Reducing and Complexing Thiol class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Tiopronin | 16 | 8 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| BioComp Pharma, Inc. | 3 | tablet, delayed release; tablet, sugar coated | Authorized generics (NDA) | September 1, 2026 |
| Mission Pharmacal Company | 3 | tablet, delayed release; tablet, sugar coated | New drug applications (NDA) | June 28, 2019 |
| Cycle Pharmaceuticals Ltd | 2 | tablet, delayed release | Generic drugs (ANDA) | January 22, 2025 |
| Par Health USA, LLC | 2 | tablet, delayed release | Generic drugs (ANDA) | June 26, 2024 |
| Teva Pharmaceuticals, Inc. | 2 | tablet, delayed release | Generic drugs (ANDA) | October 8, 2024 |
| Torrent Pharmaceuticals Limited | 2 | tablet, delayed release | Generic drugs (ANDA) | January 30, 2024 |
| Amneal Pharmaceuticals NY LLC | 1 | tablet, delayed release | Generic drugs (ANDA) | January 2, 2025 |
| Teva Pharmaceuticals USA, Inc. | 1 | tablet, sugar coated | Generic drugs (ANDA) | May 17, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, delayed release | 13 | 81.2% |
| Tablet, sugar coated | 3 | 18.8% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.